financetom
Business
financetom
/
Business
/
Canadian Solar Lowers Outlook, Warns Of Challenging Second Half
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canadian Solar Lowers Outlook, Warns Of Challenging Second Half
Aug 21, 2025 5:56 AM

Canadian Solar Inc. ( CSIQ ) shares fell Thursday after the company reported second-quarter 2025 revenue of $1.69 billion, up 4% year over year but below the $1.95 billion consensus estimate.

The company reported a net loss of 8 cents per share, compared with earnings of 2 cents a year earlier. The company posted an adjusted loss of 53 cents per share, which missed analyst expectations of a $1.61 profit.

Total module shipments reached 7.9 GW, up 14% sequentially and down 4% year over year, with the U.S., China, Pakistan, Spain, and Australia as top markets.

Also Read: Enphase Energy Secures $50 Million In New Revenue From Solar Financing Partnership

Gross margin widened to 29.8% from 17.2% a year earlier, exceeding guidance of 23% to 25%, aided by storage contributions, a U.S. anti-dumping and countervailing duty true-up adjustment, and a U.S. project sale. Gross profit rose to $505 million from $282 million a year ago.

Operating expenses increased to $377.59 million, primarily due to asset impairments. Operating cash inflow was $189 million, compared with an outflow of $429 million a year earlier.

The company ended the quarter with $2.3 billion in total cash and $6.3 billion in debt, including $1.8 billion in non-recourse borrowings.

By segment, CSI Solar delivered $1.59 billion in revenue, led by $1.02 billion from modules and $432 million from storage. Recurrent Energy contributed $104 million, with $48 million from project sales and $37 million from electricity and storage operations.

CSI Solar reported a $3 billion e-STORAGE contracted backlog, while Recurrent Energy’s development pipeline stood at 27.3 GWp of solar and 80.2 GWh of storage.

Outlook

For the third quarter, Canadian Solar ( CSIQ ) expects revenue of $1.3 billion to $1.5 billion, below the $1.63 billion estimate, and gross margin of 14% to 16%.

For the full year, it lowered sales guidance to $5.6 billion to $6.3 billion from $6.1 billion to $7.1 billion, short of the $6.33 billion consensus.

Module shipments are forecast at 25 GW to 27 GW, with storage at 7 GWh to 9 GWh.

Dr. Shawn Qu, Chairman and CEO, said, “We expect third quarter margins to moderate as difficult market conditions persist, and storage profitability reflects more recent orders at normalized levels. We narrowed our full-year module volume guidance and maintained our storage volume guidance, supported by increased visibility into the second half. Full-year revenue expectations have been adjusted to reflect certain project sales shifting into 2026 and a more measured view on module pricing. The second half will remain challenging, with rising solar supply chain prices and ongoing trade uncertainties. We will continue to navigate these conditions with discipline, maintaining a prudent balance between growth and profitability.”

Price Action: CSIQ shares were trading lower by 13.02% to $11.09 premarket at last check Thursday.

Read Next:

Trump Administration Halts Solar, Wind Project Approvals—Clean Energy ETFs Drop

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chinese cosmetics firm Yatsen Q2 revenue rises
Chinese cosmetics firm Yatsen Q2 revenue rises
Aug 21, 2025
Overview * Yatsen Q2 2025 rev rises 36.8% yr/yr to RMB1.09 bln * Net loss narrows 77.2% to RMB19.5 mln, non-GAAP net income positive * Gross margin improves to 78.3%, driven by higher-margin product sales Outlook * Yatsen expects Q3 2025 net revenues between RMB778.6 mln and RMB880.1 mln * Company forecasts Q3 2025 revenue growth of 15% to 30%...
Johnson & Johnson to invest $2 billion to boost US manufacturing as drug tariffs loom
Johnson & Johnson to invest $2 billion to boost US manufacturing as drug tariffs loom
Aug 21, 2025
(Reuters) -Johnson & Johnson ( JNJ ) committed to invest $2 billion in North Carolina on Thursday to expand the drugmaker's U.S. manufacturing presence as potential drug import duties from President Donald Trump's administration loom. J&J said it plans to build a new facility at Tokyo-based Fujifilm Diosynth's manufacturing site in Holly Springs, North Carolina, over the next 10 years....
Yatsen Reports Q2 Adjusted Earnings, Higher Revenue; Q3 Sales Outlook Set
Yatsen Reports Q2 Adjusted Earnings, Higher Revenue; Q3 Sales Outlook Set
Aug 21, 2025
05:25 AM EDT, 08/21/2025 (MT Newswires) -- Yatsen Holding ( YSG ) reported Q2 non-GAAP earnings Thursday of 0.13 Chinese renminbi ($0.02) per diluted American depositary share, swinging from a loss of 0.67 renminbi a year earlier. Analyst estimates were not readily available for comparison. Net revenue for the quarter ended June 30 was 1.09 billion renminbi, compared with 794.5...
Alvotech Says European Commission Approved Mynzepli to Treat Retinal Diseases
Alvotech Says European Commission Approved Mynzepli to Treat Retinal Diseases
Aug 21, 2025
05:29 AM EDT, 08/21/2025 (MT Newswires) -- Alvotech ( ALVO ) and UK-based Advanz Pharma said Thursday that their Mynzepli fusion protein was approved by the European Commission to treat retinal diseases, including neovascular age-related macular degeneration. The companies said the approval was based on non-clinical and clinical similarity data, which included a confirmatory efficacy study comparing Mynzepli with Bayer's...
Copyright 2023-2025 - www.financetom.com All Rights Reserved